Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Core EBITDA Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 102.84-36.0267.63-48.67-10.49

What is the latest Core EBITDA Growth ratio of NGL FINECHEM ?

The latest Core EBITDA Growth ratio of NGL FINECHEM is 102.84 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026102.84
Mar2025-36.02
Mar202467.63
Mar2023-48.67
Mar2022-10.49

How is Core EBITDA Growth of NGL FINECHEM Trending?

Years Core EBITDA Growth % Change
Mar2026 102.84
Positive
Mar2025 -36.02
Negative
Mar2024 67.63
Positive
Mar2023 -48.67
Negative
Mar2022 -10.49 -

Other Financial Ratios of NGL FINECHEM


Compare Core EBITDA Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,628.3 Cr -8.5% -5.5% 84% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -0.2% -4.9% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr 1.3% -2.3% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.5% -5.8% 29.3% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -4.2% -14.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 1.9% 5.7% 0.4% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-8.5%

-5.5%

84%

SENSEX

0.9%

-0.8%

-10.5%


You may also like the below Video Courses